Global Franchise Head CVRM, Weight Management Portfolio

Global Head, Late CVRM– Weight Management Portfolio  

Are you an inspiring Leader with extensive experience in Late-stage drug development? Would you like to apply that expertise to impact the development of life changing medicines in Weight Management and Cardiometabolic Disease?  

At AstraZeneca, your innovative discoveries will ultimately have the potential to reach millions of patients in need, all across the globe. This is the place to make a greater impact on science and patients' lives.  

We have an exciting opportunity to join AstraZeneca Late R&D, Cardiovascular, Renal and Metabolism as a Global Franchise Head for our portfolio in Weight Management and Cardiometabolic Disease. You’ll take on a senior leadership role including both people and project management, with overall accountability for delivery of the disease area strategy. Your high-level accountabilities are critical to the delivery of AZ business objectives and portfolio value targets.  This includes responsibilities for multiple assets within the weight management franchise, and multiple indications, providing strategic leadership to the cross-functional Franchise Team to ensure successful global product delivery aligned with Weight Management objectives throughout the brands' life cycles. Additionally, you will be responsible for the overall leadership of multiple indication-level Global Product Teams (GPTs) to develop and implement specific asset strategies. 

The role reports to the Senior Vice President Late CVRM and is placed at our dynamic R&D sites in Boston, Seaport Boulevard, MA, US or Gothenburg, Sweden. 

What you’ll do  

As part of developing and delivering the asset strategies you will define and drive the strategic and scientific value creation of the brands including the development path, governance approval, growth and maturity of the brands (Life Cycle Management) while integrating diverse internal and external perspectives into the process. Your accountabilities will also include:  

Development & delivery of ambitious & coherent franchise strategy 

• Accountable for the overall disease area and asset strategies and their execution including TPP, all Investment Decisions and agreements with the business 

• For indications relating to Weight Management define and drive strategic and scientific value creation across lifecycle including development, approval, launch, growth and maturity, integrating diverse internal and external perspectives 

• Partner with the Commercial VP / Lead to generate, evaluate and deliver optimal commercial strategies to maximize the franchise value. 

• Develop and maintain integrated product development plans for the franchise 

• Drive continued new value generation for the franchise including strategic focus upon Asia, Emerging Markets and Must-win commercially prioritized markets. 

• Oversee GPTs' execution of governance-approved business case